Walleye Trading
NERV icon

Walleye Trading’s Minerva Neurosciences NERV Stock Holding History

Walleye Trading’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,676
Closed -$69K – 5128
2020
Q4 		$69K Buy
+3,676
New +$92.6K ﹤0.01% 4078
2018
Q4 		– Sell
-2,250
Closed -$226K – 5074
2018
Q3 		$226K Buy
+2,250
New +$169K ﹤0.01% 3657
2018
Q2 		– Sell
-1,299
Closed -$65K – 4783
2018
Q1 		$65K Sell
1,299
-287
-18% -$13.8K ﹤0.01% 4067
2017
Q4 		$77 Buy
+1,586
New +$78.6K ﹤0.01% 3916
2016
Q2 		– Sell
-150
Closed -$7K – 5592
2016
Q1 		$7K Buy
+150
New +$6.41K ﹤0.01% 4851
2015
Q4 		– Sell
-25
Closed -$1K – 5543
2015
Q3 		$1K Buy
+25
New +$1.15K ﹤0.01% 4836

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Walleye Trading's NERV Position: Q1 2021 in Review

Walleye Trading sold out of Minerva Neurosciences (NERV) in Q1 2021, closing a stake of 3,676 shares — an estimated $69K sold.

Walleye Trading first reported a position in NERV in Q3 2015 and held it in 6 quarters. The position peaked at $226K in Q3 2018. 72 funds tracked by Wall St. Rank hold NERV as of Q1 2021.

  • Walleye Trading reported no remaining Minerva Neurosciences position as of Q1 2021 after selling out during the quarter.
  • Walleye Trading sold 3,676 Minerva Neurosciences shares in Q1 2021, an estimated $69K.
  • Walleye Trading first reported a position in Minerva Neurosciences in Q3 2015 and held it in 6 quarters.
  • Walleye Trading's Minerva Neurosciences position peaked at $226K in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2021.

Based on Walleye Trading's 13F filing for Q1 2021, filed 17 May 2021.